SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRETTI, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.049
EU - Europa 4.251
AS - Asia 2.004
SA - Sud America 18
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 6
AF - Africa 3
Totale 20.340
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.034
IT - Italia 1.464
CN - Cina 1.286
UA - Ucraina 883
TR - Turchia 641
DE - Germania 637
GB - Regno Unito 316
SE - Svezia 274
PL - Polonia 241
FI - Finlandia 184
FR - Francia 94
RU - Federazione Russa 34
ES - Italia 24
BE - Belgio 23
IN - India 18
HK - Hong Kong 15
VN - Vietnam 13
CH - Svizzera 12
IR - Iran 10
EU - Europa 9
MX - Messico 8
NL - Olanda 8
BR - Brasile 7
CA - Canada 7
EC - Ecuador 7
AT - Austria 6
RS - Serbia 6
SM - San Marino 6
AU - Australia 5
DK - Danimarca 5
IE - Irlanda 5
PT - Portogallo 5
RO - Romania 5
JP - Giappone 4
CZ - Repubblica Ceca 3
HU - Ungheria 3
LU - Lussemburgo 3
SA - Arabia Saudita 3
TH - Thailandia 3
AL - Albania 2
CO - Colombia 2
MD - Moldavia 2
MY - Malesia 2
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
HR - Croazia 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
KR - Corea 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
SI - Slovenia 1
TN - Tunisia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 20.340
Salva come PNG Salva come JPEG
Città #
Fairfield 2.120
Woodbridge 1.929
Jacksonville 1.118
Houston 1.063
Chandler 951
Ashburn 930
Seattle 840
Wilmington 724
Cambridge 718
Ann Arbor 697
Izmir 462
Nanjing 365
Princeton 284
Dearborn 237
Warsaw 237
Ferrara 204
Beijing 194
San Diego 170
Bremen 162
Boardman 130
Milan 107
Nanchang 105
Hebei 83
Falls Church 75
Rome 74
New York 73
Shenyang 70
Tianjin 67
Changsha 52
Jiaxing 51
Redwood City 48
Mountain View 47
Kunming 45
Shanghai 41
Orange 40
London 38
Bologna 37
Norwalk 37
Jinan 36
Naples 29
Hefei 28
Zhengzhou 25
Guangzhou 22
Ningbo 22
San Mateo 22
Brussels 21
Helsinki 17
Turin 17
Chicago 16
Los Angeles 16
Hong Kong 15
Parma 15
Auburn Hills 14
Indiana 14
Redmond 14
Reggio Nell'emilia 14
Florence 13
Taizhou 13
Verona 13
Padova 12
Palermo 12
Des Moines 11
Lanzhou 11
Torino 11
Changchun 10
Catania 9
Dallas 9
Dong Ket 9
Benevento 8
Lucca 8
Tappahannock 8
Ardabil 7
Genova 7
Haikou 7
Imola 7
Kilburn 7
Modena 7
Pavia 7
Wuhan 7
Acquaviva 6
Guayaquil 6
Napoli 6
Philadelphia 6
Brescia 5
Centro 5
Chieti 5
Duncan 5
Fuzhou 5
Jesi 5
Livorno 5
Montelepre 5
Mumbai 5
Paris 5
St Petersburg 5
Vienna 5
Addison 4
Alghero 4
Ambridge 4
Ancona 4
Ferentino 4
Totale 15.299
Salva come PNG Salva come JPEG
Nome #
Tumori Odontogeni misti: indagine sul significato delle correlazioni tra fibroma ameloblastico, fibro-odontoma ameloblastico e odontomi. 446
Classificazione TNM dei tumori maligni-VIII edizione: Quali novità? 321
Survival of cancer patients in Europe: the EUROCARE study 228
Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) 212
Protocollo assistenziale nelle donne a rischio ereditario di tumore della mammella e/o ovaio 210
I tumori in Emilia-Romagna 209
I tumori in Italia, rapporto 2007: sopravvivenza. 201
HLA-G 14bp polymorphism regulates the methotrexate response in rheumatoid arthritis 141
Time to viral clearance after successful conservative treatment for high-risk HPV-infected high-grade cervical intraepithelial neoplasia and early invasive squamous cervical carcinoma 138
Completeness and timeliness: Cancer registries could/should improve their performance 126
Treatment challenges in and outside a specialist network setting: Pancreatic neuroendocrine tumours 125
Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFα therapy in rheumatoid arthritis? 124
Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2) 123
Classificazione Internazionale delle malattie per l'Oncologia, terza edizione 121
Caratterizzazione biopatologica del carcinoma mammario: standardizzazione immunoistochimica 119
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project 119
Prognoses for head and neck cancers in Europe diagnosed in 1995-1999: a population-based study 118
Impact of screening programme using the faecal immunochemical test on stage of colorectal cancer: Results from the IMPATTO study 118
The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2) 117
Establishment of Keratinocyte Colonies From Small-Sized Cervical Intraepithelial Neoplasia Specimens 115
International incidence of childhood cancer, 2001-10: a population-based registry study 111
Clinical usefulness of estrogen receptor immunocytochemistry in human breast cancer 110
Cancer prevalence estimates in Europe at the beginning of 2000 110
Impatto delle cure palliative sull'assistenza dei pazienti oncologici in fase terminale in provincia di Ferrara nel 2002. 108
Worldwide comparison of survival from childhood leukaemia for 1995-2009, by subtype, age, and sex (CONCORD-2): a population-based study of individual data for 89828 children from 198 registries in 53 countries 108
Early (short-interval) rescreen in mammography screening 107
Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects 106
Estimates of cancer burden in Emilia-Romagna 106
Annual mammography at age 45-49 years and biennial mammography at age 50-69 years: comparing performance measures in an organised screening setting 106
Regional inequalities in cancer care persist in Italy and can influence survival. 105
Coping with problems that flaw the estimate of mammography sensitivity in population-based screening programmes: the Italian perspective 105
Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy 105
Cancer incidence and mortality trends from 2003 to 2014 in Italy 105
Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma 104
null 104
Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet - a population-based study 104
Modulation of biomarkers in minimal breast carcinoma 103
p53 expression in colorectal cancer: relation to tumor type, DNA ploidy pattern and short-term survival. 103
Population-based method for investigating adherence to international recommendations for pathology reporting of primary cutaneous melanoma: Results of a EUROCARE-5 high resolution study 103
Application of quantitative analysis to biologic profile evaluation in breast cancer 103
Interpretation of colposcopy in population-based cervical screening services in north-eastern Italy: an online interregional agreement study 103
Epidemiology of rare cancers and inequalities in oncologic outcomes 103
Breast screening: axillary lymph node status of interval cancers by interval year 102
Incidence, survival and prevalence of myeloid malignancies in Europe 102
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe 102
Survival of European patients with central nervous system tumors 100
The advantage of women in cancer survival: An analysis of EUROCARE-4 data 100
Estimates of cancer burden in Italy 99
Incidence and survival trends of cervical adenocarcinoma in Italy: Cytology screening has become more effective in downstaging the disease but not in detecting its precursors 99
The burden of HPV-related diseases in Italy, 2001-12 99
Comparative cancer survival information in Europe 99
Evaluation of service mammography screening impact in Italy. The contribution of hazard analysis 98
null 98
Survival of European patients diagnosed with myeloid malignancies: a HAEMACARE study 98
Treatment challenges in and outside a network setting: Soft tissue sarcomas 98
Estimated and observed cancer incidence in Italy: a validation study. 97
Rare cancers of the head and neck area in Europe 97
Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade 97
Rare cancers are not so rare: the rare cancer burden in Europe 96
Cancer incidence and mortality in the province of Ferrara 1989-1990 96
Changes in cervical cancer incidence following the introduction of organized screening in Italy 96
Incidence, prevalence and survival of patients with rare epithelial digestive cancers diagnosed in Europe in 1995-2002 95
Incidence and survival of rare urogenital cancers in Europe 95
Trends in net survival from liver cancer in six European Latin countries: results from the SUDCAN population-based study 95
null 94
Mib-1 proliferative activity in invasive breast cancer measured by image analysis 94
null 94
The burden of rare cancers in Italy: the surveillance of rare cancers in Italy (RITA) project. 94
The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods 94
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the " Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 94
Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: Results of EUROCARE-5, a population-based study 94
null 93
Registro Tumori della provincia di Ferrara 93
null 93
null 93
Rare Ovarian Tumours: Epidemiology, Treatment Challenges in and outside a Network Setting 93
Long-term survival, prevalence, and cure of cancer: A population-based estimation for 818,902 Italian patients and 26 cancer types 93
Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe 92
Rare thoracic cancers, including peritoneum mesothelioma 92
Methodological aspects of estimating rare cancer prevalence in Europe: The experience of the RARECARE project 92
Ageing and other factors behind recent cancer incidence and mortality trends in Italy 92
null 92
Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5--a population-based study 91
National estimates of cancer patients survival in italy: A model-based method 90
null 90
null 90
EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary 90
Epidemiology of glial and non-glial brain tumours in Europe 90
Quality analysis of population-based information on cancer stage at diagnosis across Europe, with presentation of stage-specific cancer survival estimates: A EUROCARE-5 study 89
Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5 88
Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002 88
A simple method to estimate the episode and programme sensitivity of breast cancer screening programmes 88
Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project 87
Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project 87
Invasive extramammary Paget's disease and the risk for secondary tumours in Europe 87
Treatment challenges in and outside a network setting: Head and neck cancers 87
Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy 87
Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: Comparison between European population-based data (EUROCARE-5) 87
null 86
null 86
Totale 11.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 74.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.387
Totale 77.247
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.392 0 0 0 0 0 0 0 0 0 539 667 1.186
2019/20205.119 841 178 190 729 387 709 549 521 423 340 148 104
2020/20213.526 232 268 274 407 265 314 155 416 179 410 367 239
2021/20222.556 87 296 205 167 129 144 136 195 109 204 188 696
2022/20232.594 313 127 52 267 490 382 61 256 332 34 170 110
2023/2024927 171 169 60 75 99 125 62 74 44 48 0 0
Totale 20.832